1

Dermatological Market (By Dermatological Disease: Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia; By Drug Type: Prescription-Based Drugs, Over-the-Counter Drugs; By Route of Administration: Topical, Oral, Parenteral Administration) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Dermatological
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Dermatological Market By Dermatological Disease
     1.2.2.1. Global Dermatological Market Revenue and Growth Rate Comparison By Dermatological Disease(2016-2027)
     1.2.2.2. Global Dermatological Market Revenue Share By Dermatological Disease in 2019
     1.2.2.3. Acne
     1.2.2.4. Dermatitis
     1.2.2.5. Psoriasis
     1.2.2.6. Skin Cancer
     1.2.2.7. Rosacea
     1.2.2.8. Alopecia
   1.2.3. Dermatological Market By Drug Type
     1.2.3.1. Global Dermatological Market Revenue and Growth Rate Comparison By Drug Type (2016-2027)
     1.2.3.2. Global Dermatological Market Revenue Share By Drug Type in 2019
       1.2.3.2.1. Prescription-Based Drugs
       1.2.3.2.2. Over-the-Counter Drugs
   1.2.4. Dermatological Market By Route of Administration
     1.2.4.1. Global Dermatological Market Revenue and Growth Rate Comparison By Route of Administration(2016-2027)
     1.2.4.2. Global Dermatological Market Revenue Share By Route of Administration in 2019
       1.2.4.2.1. Topical
       1.2.4.2.2. Oral
       1.2.4.2.3. Parenteral Administration
   1.2.5. Dermatological Market By Geography
     1.2.5.1. Global Dermatological Market Revenue and Growth Rate Comparison by Geography (2016-2027)
     1.2.5.2. North America Dermatological Market Revenue and Growth Rate(2016-2027)
     1.2.5.3. Europe Dermatological Market Revenue and Growth Rate(2016-2027)
     1.2.5.4. Asia-Pacific Dermatological Market Revenue and Growth Rate(2016-2027)
     1.2.5.5. Latin America Dermatological Market Revenue and Growth Rate(2016-2027)
     1.2.5.6. Middle East and Africa (MEA)Dermatological Market Revenue and Growth Rate(2016-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING Dermatological ANALYSIS
3.1. Capacity and Commercial Production Date of Global Dermatological Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Dermatological Major Manufacturers in 2019
3.3. R&D Status and Manufacturing End-User of Global Dermatological Major Manufacturers in 2019
3.4. Raw Materials End-Users Analysis of Global Dermatological Major Manufacturers in 2019

CHAPTER 4. Dermatological MARKET By Dermatological Disease
4.1. Global Dermatological Revenue By Dermatological Disease
4.2. Acne
   4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Dermatitis
   4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Psoriasis
   4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.5. Skin Cancer
   4.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.6. Rosacea
   4.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.7. Alopecia
   4.7.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.7.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 5. Dermatological MARKET By Drug Type
5.1. Global Dermatological Revenue By Drug Type
5.2. Prescription-Based Drugs
   5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Over-the-Counter Drugs
   5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 6. Dermatological MARKET By Route of Administration
6.1. Global Dermatological Revenue By Route of Administration
6.2. Topical
   6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.3. Oral
   6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.4. Parenteral Administration
   6.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 7. NORTH AMERICA Dermatological MARKET BY COUNTRY
7.1. North America Dermatological Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2. North America Dermatological Market Revenue Share Comparison, 2016 & 2027 (%)
7.3. U.S.
   7.3.1. U.S. Dermatological Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   7.3.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   7.3.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   7.4.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   7.4.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)

CHAPTER 8. EUROPE SMART REFRIGERATOR MARKET BY COUNTRY
8.1. Europe Dermatological Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. Europe Dermatological Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   8.3.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   8.3.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   8.4.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   8.4.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   8.5.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   8.5.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   8.6.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   8.6.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   8.7.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   8.7.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)

CHAPTER 9. ASIA-PACIFIC Dermatological MARKET BY COUNTRY
9.1. Asia-Pacific Dermatological Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Asia-Pacific Dermatological Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   9.3.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   9.3.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   9.4.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   9.4.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   9.5.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   9.5.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   9.6.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   9.6.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   9.7.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   9.7.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   9.8.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   9.8.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)

CHAPTER 10. LATIN AMERICA Dermatological MARKET BY COUNTRY
10.1. Latin America Dermatological Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Latin America Dermatological Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   10.3.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   10.3.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   10.4.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   10.4.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   10.5.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   10.5.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA Dermatological MARKET BY COUNTRY
11.1. Middle East & Africa Dermatological Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Middle East & Africa Dermatological Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   11.3.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   11.3.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   11.4.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   11.4.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Dermatological Disease, 2016 - 2027 ($Million)
   11.5.2. Market Revenue and Forecast By Drug Type, 2016 - 2027 ($Million)
   11.5.3. Market Revenue and Forecast By Route of Administration, 2016 - 2027 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Merck KGaA
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Product Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Bayer AG
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Product Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. Johnson & Johnson
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Product Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Novartis AG
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Product Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. GlaxoSmithKline plc
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Product Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. AstraZeneca
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Product Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Galderma S.A.
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Product Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. AbbVie Inc.
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Product Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Pfizer Inc.
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Product Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Others
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Product Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary